Pula, Croatia

Lara Jurković

This inventor holds 1 USPTO granted patent. Top assignee: Deciphera Pharmaceuticals, LLC. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lara Jurković. Retrieved from https://idiyas.com/inventor/lara-jurkovic-0c9dqc5t

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lara Jurković: Innovator in Pharmaceutical Science

Introduction

Lara Jurković is a notable inventor based in Pula, Croatia. She has made significant contributions to the field of pharmaceutical science, particularly in the development of solid-state forms of ripretinib. Her work is essential in advancing treatment options for patients.

Latest Patents

Lara holds a patent for "Solid state forms of ripretinib." This patent encompasses the processes for the preparation of these solid-state forms, as well as a pharmaceutical composition that includes them. This innovation is crucial for enhancing the efficacy and stability of ripretinib in medical applications.

Career Highlights

Lara is currently employed at Deciphera Pharmaceuticals, LLC, where she continues to push the boundaries of pharmaceutical research. Her expertise and dedication have positioned her as a valuable asset in her field.

Collaborations

Lara collaborates with talented professionals such as Sanja Matečič Mušanić and Valentina Travančić. Together, they contribute to the innovative environment at Deciphera Pharmaceuticals, fostering advancements in drug development.

Conclusion

Lara Jurković exemplifies the spirit of innovation in the pharmaceutical industry. Her work on ripretinib solid-state forms showcases her commitment to improving patient outcomes through scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…